Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs aimed toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where cure alternatives remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/opt-token-to-list-on-xt-com-as-optio-blockchain-expands-with-edgecast-cloud-relaunch/